Cargando…
Protein Modification by Dicarbonyl Molecular Species in Neurodegenerative Diseases
Neurodegeneration results from abnormalities in cerebral metabolism and energy balance within neurons, astrocytes, microglia, or microvascular endothelial cells of the blood-brain barrier. In Alzheimer's disease, β-amyloid is considered the primary contributor to neuropathology and neurodegener...
Autores principales: | Williams, Wesley M., Weinberg, Aaron, Smith, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276062/ https://www.ncbi.nlm.nih.gov/pubmed/22332001 http://dx.doi.org/10.4061/2011/461216 |
Ejemplares similares
-
Modification of β-Defensin-2 by Dicarbonyls Methylglyoxal and Glyoxal Inhibits Antibacterial and Chemotactic Function In Vitro
por: Kiselar, Janna G., et al.
Publicado: (2015) -
Dicarbonyl Stress in Diabetic Vascular Disease
por: Stratmann, Bernd
Publicado: (2022) -
Dicarbonyl stress, protein glycation and the unfolded protein response
por: Rabbani, Naila, et al.
Publicado: (2021) -
Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics
por: Rabbani, Naila, et al.
Publicado: (2016) -
Dicarbonyl stress in clinical obesity
por: Masania, Jinit, et al.
Publicado: (2016)